Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
4 | 4 | PSYCHIATRY//PSYCHOLOGY, CLINICAL//PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 1867560 |
128 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//HEALTH LITERACY//INFORMED CONSENT | 68930 |
2219 | 2 | GENERIC DRUGS//ORPHAN DRUGS//GENERIC SUBSTITUTION | 5103 |
18631 | 1 | DRUG LAG//PRIORITY REVIEW//CONDITIONAL APPROVAL | 566 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DRUG LAG | authKW | 696023 | 3% | 83% | 15 |
2 | PRIORITY REVIEW | authKW | 346938 | 2% | 69% | 9 |
3 | CONDITIONAL APPROVAL | authKW | 303156 | 1% | 78% | 7 |
4 | JAPANESE CLINICAL TRIALS | authKW | 222729 | 1% | 100% | 4 |
5 | OFF PHARMACEUT IND | address | 198862 | 1% | 71% | 5 |
6 | STUDY DRUG DEV | address | 168423 | 2% | 28% | 11 |
7 | CLIN TRIAL GUIDANCE | address | 167047 | 1% | 100% | 3 |
8 | PRESCRIPTION DRUG USER FEE ACT OF 1992 | authKW | 167047 | 1% | 100% | 3 |
9 | REVIEW AUDIT | address | 167047 | 1% | 100% | 3 |
10 | DRUG APPROVAL | authKW | 162075 | 3% | 15% | 19 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4674 | 53% | 0% | 298 |
2 | Health Care Sciences & Services | 2632 | 15% | 0% | 85 |
3 | Health Policy & Services | 1285 | 8% | 0% | 46 |
4 | Medical Informatics | 730 | 5% | 0% | 26 |
5 | Medicine, General & Internal | 171 | 10% | 0% | 54 |
6 | Social Sciences, Biomedical | 143 | 2% | 0% | 13 |
7 | Medicine, Legal | 136 | 2% | 0% | 10 |
8 | Oncology | 106 | 9% | 0% | 52 |
9 | Biotechnology & Applied Microbiology | 59 | 6% | 0% | 33 |
10 | Law | 53 | 2% | 0% | 12 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | OFF PHARMACEUT IND | 198862 | 1% | 71% | 5 |
2 | STUDY DRUG DEV | 168423 | 2% | 28% | 11 |
3 | CLIN TRIAL GUIDANCE | 167047 | 1% | 100% | 3 |
4 | REVIEW AUDIT | 167047 | 1% | 100% | 3 |
5 | PHARMACEUT REGULATORY SCI | 154931 | 1% | 35% | 8 |
6 | ONCOLCHUO KU | 111364 | 0% | 100% | 2 |
7 | REGULATORY POLICY INTELLIGENCE | 111364 | 0% | 100% | 2 |
8 | DRUG DEV REGULATORY SCI | 80987 | 1% | 36% | 4 |
9 | INNOVAT STUDIES GRP | 80173 | 1% | 24% | 6 |
10 | PHARMACEUT MED DEVICES EVALUAT | 71582 | 1% | 21% | 6 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DRUG INFORMATION JOURNAL | 80915 | 7% | 4% | 40 |
2 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 79540 | 4% | 6% | 24 |
3 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 23511 | 9% | 1% | 50 |
4 | CLINICAL RESEARCH AND REGULATORY AFFAIRS | 18900 | 1% | 6% | 6 |
5 | MANAGERIAL AND DECISION ECONOMICS | 7225 | 1% | 2% | 6 |
6 | JOURNAL OF CLINICAL PHARMACOLOGY | 5786 | 4% | 0% | 24 |
7 | INTERNATIONAL JOURNAL OF HEALTH SERVICES | 2993 | 2% | 1% | 9 |
8 | PHARMACY INTERNATIONAL | 2780 | 1% | 1% | 5 |
9 | NATURE REVIEWS DRUG DISCOVERY | 2081 | 1% | 1% | 6 |
10 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1708 | 3% | 0% | 16 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DRUG LAG | 696023 | 3% | 83% | 15 | Search DRUG+LAG | Search DRUG+LAG |
2 | PRIORITY REVIEW | 346938 | 2% | 69% | 9 | Search PRIORITY+REVIEW | Search PRIORITY+REVIEW |
3 | CONDITIONAL APPROVAL | 303156 | 1% | 78% | 7 | Search CONDITIONAL+APPROVAL | Search CONDITIONAL+APPROVAL |
4 | JAPANESE CLINICAL TRIALS | 222729 | 1% | 100% | 4 | Search JAPANESE+CLINICAL+TRIALS | Search JAPANESE+CLINICAL+TRIALS |
5 | PRESCRIPTION DRUG USER FEE ACT OF 1992 | 167047 | 1% | 100% | 3 | Search PRESCRIPTION+DRUG+USER+FEE+ACT+OF+1992 | Search PRESCRIPTION+DRUG+USER+FEE+ACT+OF+1992 |
6 | DRUG APPROVAL | 162075 | 3% | 15% | 19 | Search DRUG+APPROVAL | Search DRUG+APPROVAL |
7 | CETA | 148483 | 1% | 67% | 4 | Search CETA | Search CETA |
8 | CENTRALIZED PROCEDURE | 127270 | 1% | 57% | 4 | Search CENTRALIZED+PROCEDURE | Search CENTRALIZED+PROCEDURE |
9 | ETHNIC FACTORS | 127262 | 1% | 29% | 8 | Search ETHNIC+FACTORS | Search ETHNIC+FACTORS |
10 | PMDA | 127262 | 1% | 29% | 8 | Search PMDA | Search PMDA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |